Cytarabine and Clostridium difficile colitis - a phase IV clinical study of FDA data

Summary:

We study 53,624 people who have side effects when taking Cytarabine. Clostridium difficile colitis is found, especially among people who are male, 2-9 old, have been taking the drug for < 1 month, also take Oncaspar and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people take Cytarabine and have Clostridium difficile colitis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jul, 14, 2023

53,624 people reported to have side effects when taking Cytarabine.
Among them, 544 people (1.01%) have Clostridium difficile colitis.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is used in acute myelogenous leukemia (aml) - adult. Currently, eHealthMe is studying from 60,548 Cytarabine users.

What is Clostridium difficile colitis?

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection) is found to be associated with 2,138 drugs and 1,728 conditions by eHealthMe. Currently, we are studying 13,142 people who have Clostridium difficile colitis.

Number of Cytarabine and Clostridium difficile colitis reports submitted per year:

Could Cytarabine cause Clostridium difficile colitis?

Time on Cytarabine when people have Clostridium difficile colitis *:

Click here to view

Gender of people who have Clostridium difficile colitis when taking Cytarabine*:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Clostridium difficile colitis?

Check whether Clostridium difficile colitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Cytarabine side effects by duration, gender and age:

Cytarabine side effects (60,548 reports)

Clostridium difficile colitis treatments and more:

Clostridium difficile colitis (13,142 reports)

Common drugs associated with Clostridium difficile colitis:

All the drugs that are associated with Clostridium difficile colitis:

Clostridium difficile colitis (2,138 drugs)

Common conditions associated with Clostridium difficile colitis:

Multiple myeloma: 766 reports
High blood pressure: 709 reports
Acute lymphocytic leukemia (all): 472 reports
Pain: 463 reports
Crohn's disease: 358 reports
Urinary tract infection: 338 reports
Multiple sclerosis: 332 reports

All the conditions that are associated with Clostridium difficile colitis:

Clostridium difficile colitis (1,728 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.